Search research articles
Contact Us
Filters
Showing results (81-90 of 331) with videos related to
Page
of 34
Sort By:
Cancer Treatment and Research
|
February 21, 2008
Does reimbursement affect physicians' decision making? Examples from the use of recombinant erythropoietin
June M McKoy, Cara C Tigue, Charles L Bennett
Expert Opinion on Drug Safety
|
May 5, 2020
Response to: letter to the editor: consideration on 'an evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the food and drug administration and the European medicines agency' by bennett et al
Andrew C Bennett, Charles L Bennett, Bartlett J Witherspoon
Seminars in Oncology
|
July 4, 2002
Cost-effectiveness considerations in the treatment of essential thrombocythemia
Robert Golub, Jared Adams, Sundeep Dave, et al.
Urology
|
November 19, 2013
Editorial comment
Sandip M Prasad, A Oliver Sartor, Charles L Bennett
JAMA Oncology
|
December 15, 2015
Associations Between Industry Sponsorship and Results of Cost-effectiveness Analyses of Drugs Used in Breast Cancer Treatment
Jordan D Lane, Mark W Friedberg, Charles L Bennett
Leukemia Research
|
April 1, 2016
Evaluation of gemtuzumab ozogamycin associated sinusoidal obstructive syndrome: Findings from an academic pharmacovigilance program review and a pharmaceutical sponsored registry
Jametta S Magwood-Golston, Samuel Kessler, Charles L Bennett
Drugs
|
November 18, 2018
Why Biologics and Biosimilars Remain So Expensive: Despite Two Wins for Biosimilars, the Supreme Court's Recent Rulings do not Solve Fundamental Barriers to Competition
Brian K Chen, Y Tony Yang, Charles L Bennett
Urology
|
January 28, 2015
Editorial comment
Terhi Hermanson, Oliver Sartor, Richard Ablin, et al.
JAMA Oncology
|
February 17, 2017
Improving the Evidence Base for Delivery of High-Quality Cancer Care
Zaina P Qureshi, Patricia A Ganz, Charles L Bennett
Cancer Treatment and Research
|
December 15, 2007
The economics of brain metastases
Charles L Bennett, Cara C Tigue, Karen A Fitzner
Page
of 34
Search research articles
Search
Showing results (81-90 of 331) with videos related to
Sort By:
Page
of 34
Cancer Treatment and Research
|
February 21, 2008
Does reimbursement affect physicians' decision making? Examples from the use of recombinant erythropoietin
June M McKoy, Cara C Tigue, Charles L Bennett
Expert Opinion on Drug Safety
|
May 5, 2020
Response to: letter to the editor: consideration on 'an evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the food and drug administration and the European medicines agency' by bennett et al
Andrew C Bennett, Charles L Bennett, Bartlett J Witherspoon
Seminars in Oncology
|
July 4, 2002
Cost-effectiveness considerations in the treatment of essential thrombocythemia
Robert Golub, Jared Adams, Sundeep Dave, et al.
Urology
|
November 19, 2013
Editorial comment
Sandip M Prasad, A Oliver Sartor, Charles L Bennett
JAMA Oncology
|
December 15, 2015
Associations Between Industry Sponsorship and Results of Cost-effectiveness Analyses of Drugs Used in Breast Cancer Treatment
Jordan D Lane, Mark W Friedberg, Charles L Bennett
Leukemia Research
|
April 1, 2016
Evaluation of gemtuzumab ozogamycin associated sinusoidal obstructive syndrome: Findings from an academic pharmacovigilance program review and a pharmaceutical sponsored registry
Jametta S Magwood-Golston, Samuel Kessler, Charles L Bennett
Drugs
|
November 18, 2018
Why Biologics and Biosimilars Remain So Expensive: Despite Two Wins for Biosimilars, the Supreme Court's Recent Rulings do not Solve Fundamental Barriers to Competition
Brian K Chen, Y Tony Yang, Charles L Bennett
Urology
|
January 28, 2015
Editorial comment
Terhi Hermanson, Oliver Sartor, Richard Ablin, et al.
JAMA Oncology
|
February 17, 2017
Improving the Evidence Base for Delivery of High-Quality Cancer Care
Zaina P Qureshi, Patricia A Ganz, Charles L Bennett
Cancer Treatment and Research
|
December 15, 2007
The economics of brain metastases
Charles L Bennett, Cara C Tigue, Karen A Fitzner
Page
of 34